TY - JOUR T1 - Grazoprevir plus elbasvir in treatment-naive and treatment experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study. JF - Lancet Y1 - 2015 A1 - Roth, D. A1 - David R. Nelson A1 - Bruchfeld, A. A1 - et, al VL - 386 SP - 1537-1545 IS - 10003 ER -